(Q61980380)
Statements
A Study to Evaluate the Efficacy of Rosiglitazone (BRL-049653) on Reduction of Microalbuminuria in Subjects With Type 2 Diabetes Mellitus (English)
0 references
April 2000
0 references
336
0 references
40 year
0 references
80 year
0 references